One-Stop Solution
From Gene Synthesis
To Cryo-EM Structure
Biortus is a leading world-class contract research organization that provides a one-stop service of gene synthesis to structure determination. Since 2009, Biortus has partnered worldwide with numerous research institutions, pharmaceutical and biotechnology companies - consistently providing high-quality custom proteins for all stages of biomedical research.
What we do ?
To help our clients achieve their drug discovery goals, we have established three world-class research platforms. These are Protein Production, Structural Biology (Crystallography, Cryo-EM, and MicroED), and In Vitro Assays and Screening.
-
Every year, the Biortus protein production team successfully delivers over 5000 batches customized recombinant proteins, mostly drug target proteins, to our clients, including enzymes, kinases, transcription factors, immunity related proteins, GPCRs, Transporters, Solute Carrier Family members (SLCs), E3 ligases, epigenetic proteins and others.
Plasmid Construction Expression Systems Purification Procedures Quality Control -
Compound screening against a drug target is a vital step in early stage drug discovery. Biortus has an extensive collection of testing equipment that allows development of many kinds of biochemical assays, biophysical assays, and cell-based assays.
Instrumentations Established Assays Fragment Libraries -
Compound screening against a drug target is a vital step in early stage drug discovery. Biortus has an extensive collection of testing equipment that allows development of many kinds of biochemical assays, biophysical assays, and cell-based assays.
Crystallography Cryo-EM MicroED Computational Structural Biology
Biortus Protein Catalogue
20000+ Plasmids!
6000+ Drug Targets!
300+ Membrane Proteins!
Biortus now provides an off-the-shelf Protein Catalogue through our subsidiary, Biortus USA, to better serve the global life science industry at the same high quality. Many of these proteins have been crystallized and/or structurally elucidated using our in-house X-ray and Cryo-EM facilities. The Biortus Protein Catalogue currently comprises of over 1,700 independent drug targets, consisting of Membrane Proteins, Kinases, ubiquitin-proteasome enzymes (DUBS and E3 Ligases), CDKs (cyclin and cyclin dependent kinases) and more, covering a wide range of therapeutic areas.
Biortus: Your Preferred Partner
Biortus’s core capabilities include target protein production, biochemical / biophysical / cellular assay development, compound screening and characterization, X-ray crystallography, cryo-EM for protein structure determination (SPA), and MicroED for small molecule crystal form and structure characterization. Biortus’s service is highly recognized by clients with co-authorship in more than 10 publications in prestigious journals including Science, Cell, Cell Research, Nature Communications, and JACS etc.
News
Jun 14,2024
Biortus Announces Strategic Collaboration with Schrödinger
Mar 01,2024
Go BIG! - Purification and Structural Determination of RyR1, 2.3MDa membrane protein
Feb 17,2023
Biortus Delivering hERG Protein and Cryo-EM Structures
Apr 26,2022
Biortus Delivering ABCB10 Protein and Cryo-EM Structures
Apr 26,2022
Installed Krios G4 Boosts Productivity at Biortus CryoEM Center
May 03,2021